234 related articles for article (PubMed ID: 33445451)
1. Sulforaphane Inhibits Osteoclastogenesis via Suppression of the Autophagic Pathway.
Luo T; Fu X; Liu Y; Ji Y; Shang Z
Molecules; 2021 Jan; 26(2):. PubMed ID: 33445451
[TBL] [Abstract][Full Text] [Related]
2. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway.
Liu S; Zhu L; Zhang J; Yu J; Cheng X; Peng B
Biochem Pharmacol; 2016 Apr; 106():82-93. PubMed ID: 26947453
[TBL] [Abstract][Full Text] [Related]
3. Anti-osteoclastogenesis of Mineral Trioxide Aggregate through Inhibition of the Autophagic Pathway.
Cheng X; Zhu L; Zhang J; Yu J; Liu S; Lv F; Lin Y; Liu G; Peng B
J Endod; 2017 May; 43(5):766-773. PubMed ID: 28292604
[TBL] [Abstract][Full Text] [Related]
4. JNK1 regulates RANKL-induced osteoclastogenesis
Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
[TBL] [Abstract][Full Text] [Related]
5. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
Zhang G; Wang Y; Tang G; Ma Y
BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
[TBL] [Abstract][Full Text] [Related]
6. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Li L; Sapkota M; Kim SW; Soh Y
Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
Zhong J; Wang Z; Yuan W; Shen Y; Chen L
Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
[TBL] [Abstract][Full Text] [Related]
8. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Laha D; Deb M; Das H
Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
[TBL] [Abstract][Full Text] [Related]
9. Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.
Yang X; Gao W; Wang B; Wang X; Guo H; Xiao Y; Kong L; Hao D
J Cell Biochem; 2017 Dec; 118(12):4479-4486. PubMed ID: 28464271
[TBL] [Abstract][Full Text] [Related]
10. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
11. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
12. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
[TBL] [Abstract][Full Text] [Related]
13. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane-N-Acetyl-Cysteine Induces Autophagy Through Activation of ERK1/2 in U87MG and U373MG Cells.
Liu HJ; Wang L; Kang L; Du J; Li S; Cui HX
Cell Physiol Biochem; 2018; 51(2):528-542. PubMed ID: 30458452
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
[TBL] [Abstract][Full Text] [Related]
16. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
[TBL] [Abstract][Full Text] [Related]
17. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
[TBL] [Abstract][Full Text] [Related]
19. Orcinol gentiobioside inhibits RANKL-induced osteoclastogenesis by promoting apoptosis and suppressing autophagy via the JNK1 signaling.
Lian C; Gong W; Zhao X; Sun P; Hu S; Zhou G; Zhang Q; Qin L
J Ethnopharmacol; 2024 Jun; 328():118060. PubMed ID: 38521429
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1 regulates ERK1/2 signaling pathway and autophagy activation in wear particle-induced osteoclastogenesis.
Wang L; Gao Z; Zhang J; Huo Y; Xu Q; Qiu Y
Cell Biol Int; 2021 Mar; 45(3):612-622. PubMed ID: 33386763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]